OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Yuezhou Zhang, Huaguang Cui, Ruiqi Zhang, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Smart nanoparticles for cancer therapy
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 366

Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy
Chendi Ding, Chunbo Chen, Xiaowei Zeng, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13513-13553
Open Access | Times Cited: 98

Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84

Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
Chaoping Fu, Xing-Yu Cai, Silin Chen, et al.
Polymers (2023) Vol. 15, Iss. 10, pp. 2317-2317
Open Access | Times Cited: 59

A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy
He Wang, Zhiyuan Gao, Di Jiao, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 16
Closed Access | Times Cited: 52

Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 26

Revolutionizing Prostate Cancer Therapy: Artificial intelligence – based Nanocarriers for Precision Diagnosis and Treatment
Moein Shirzad, Afsaneh Salahvarzi, Sobia Razzaq, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104653-104653
Closed Access | Times Cited: 3

Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
Xiujuan Xiang, Xuan Feng, Shaojin Lu, et al.
Exploration (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 54

Recent Progress in Carrier‐Free Nanomedicine for Tumor Phototherapy
Yingtao Zhong, Yi Cen, Lin Xu, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 4
Closed Access | Times Cited: 49

Self-targeting platinum(IV) amphiphilic prodrug nano-assembly as radiosensitizer for synergistic and safe chemoradiotherapy of hepatocellular carcinoma
Xiaohui Xiao, Yupeng Wang, Jieyao Chen, et al.
Biomaterials (2022) Vol. 289, pp. 121793-121793
Closed Access | Times Cited: 38

Hierarchical Microparticles Delivering Oxaliplatin and NLG919 Nanoprodrugs for Local Chemo-immunotherapy
Qingfei Zhang, Gaizhen Kuang, Yunru Yu, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 43, pp. 48527-48539
Closed Access | Times Cited: 38

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
Qing Pei, Bowen Jiang, Dengyuan Hao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3252-3276
Open Access | Times Cited: 27

Matrix Metalloproteinase-2-Induced Morphologic Transformation of Self-Assembled Peptide Nanocarriers Inhibits Tumor Growth and Metastasis
Juanjuan Cao, Xiaomeng Yuan, Xinyu Sun, et al.
ACS Materials Letters (2023) Vol. 5, Iss. 3, pp. 900-908
Closed Access | Times Cited: 26

Recent Progress in Implantable Drug Delivery Systems
Guangqin He, Haimei Li, Junyi Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 10

Melanin/melanin-like nanoparticles in tumor photothermal and targeted therapies
Jing Wu, Yilin Xu, Donghai Wu, et al.
International Journal of Pharmaceutics (2025), pp. 125354-125354
Open Access | Times Cited: 1

Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle
Dezhi Sui, Yanzhi Song, Yihui Deng
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 38

A Paclitaxel Prodrug with Copper Depletion for Combined Therapy toward Triple-Negative Breast Cancer
Dengyuan Hao, Qian Meng, Chaonan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12383-12393
Closed Access | Times Cited: 21

A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy
Weiling Zhuo, Wanyu Wang, Wenjie Zhou, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 8

A Polyplatin with Hands‐Holding Near‐Infrared‐II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment Feedback
Yingjie Yu, Dengshuai Wei, Tiejun Bing, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 8

Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety
Bowen Zhang, Lingxiao Li, Minglong Huang, et al.
Nano Letters (2024) Vol. 24, Iss. 12, pp. 3759-3767
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top